Seven strains of group B streptococcus (GBS) of various types were examined for their virulence in adult and neonates mice by intraperitonea and intracerebra inoculations. The neonates mice were commonly more sensitive against the challenge than the adult mice. Pregnant mice were immunized with anti type Ia antiserum or heat-killed vaccine, and inoculated with GBS intravaginally before the parturition. The mean number of per litter delivered from normal 13.7, while GBS-inoculated control pregnants was 3.8 or less. Those values obtained from pre-immunized pregnants were intermediates. The neonates which delivered from actively or adoptively immunized pregnants showed significantly higher protectivity against challenge of homologous and heterologous type strains than those of neonates from normal pregnants. It is concluded that either active or adoptive maternal immunization in mice resulted the vertical protectivity against challenge of homologous and heterologous type (III) organisms.
Introduction
Group B streptococcus (GBS) has been recognized as the main etiological agent of serious neonatal diseases. Vaginal carriage of GBS is common among pregnant nmoomo, and their neonates are frequently contaminated with the organisms. There are many reports in which the anti-GBS human or rabbit antisera as well as the globulin fractions showed protective activity in adult mice1)'6). We have also previously described on the passive immunization in adult mice using the type specific rabbit antisera7). There are no reports on the protection test in neonatal animala, except for neonate rats and chicken embryo8)9). These reports demonstrated the protectivity of the animal itself. The present investigation was designed to examine the virulence of GBS in neonate, and the effects of the materna immunization on the indirect protectivity against group B streptococcal infection in their neonate mice.
Materials and Methods
Streptococcal strains. Prototype strains employed were O90 (type Ia), H36B (type Ib),V9 (type II) and M216 (type III) (from the Culture Collection of the Institute of Medical Science, University of Tokyo), and A909 (type Ic, from Dr. Maekawa, Sapporo Medical School). Also, clunical isolates of 59 (type Io)and Yagura (type III) from the patients without and with group B streptococcal disease, respectively, were obtained from Dr. Iimura, Metropolitan Toshima Hospital. These strains were passaged in mice a few times by the method of Lancefield et al. 1) Bacterial cultures in Todd-Hewitt broth (THB) were frozen in 1 ml portions until use.
The strain 59 is used for preparation of vaccine: 0.3% formalinized vaccine used for antisera preparation Table  2 footnote)10). Statistically analysis.
The chi-square test was used to determine the significance of differences. The
Yates correction was used when numbers were small in any of the subgroups. Probability level of p<0.05
were considered significant.
Results
Lethal dose of GBS in mice of difference ages and routes. Results are shown in the Figure  1 . Four type I Figure   1 . Relation of LD50 of strains to mouse age and administration route. The passive immunization (IV) was performed with 0.1 ml of 1: 10 diluted antiserum. The oarenthsis is schedule of treatment, and one day is-.
The vaccine (IV) was performed with 0.1 ml of 2.4 •~ 108 heat-killed 59 cells 3 times every 3 days.
No immunization as control.
strains were considerably virulent to both age groups, and other type strains were moderate to low virulent.
The neonate mice were commonly more sensitive than the adult mice, especially to type III infection, in which differences were 103 to 104 orders. Virulence by IC route were commonly higher than those of IP route, especially in type III infection. The strain 59 and M216 were used for the following experiments. Table 2 . Isolation of GBS from alive neonates delivered from inoculated pregnants.
Specimens from sacrificed neonates were spread on NO agar, which was performed with Heart Infusion agar containing the 0.3% yeast extract, the 0.001% colimycin, the 0.0015% nalidixic acid, the 0.0001% crystal violet and the 5% horse blood.
On astrisks, see the legend of table 1. inoculation was examined (Table 3) . Either the passively immnuized or the vaccinated group showed significantly higher protection against both challenge than the controls. Serum antibody titers of peurperal immunized mice. As shown in Table 4 , both of agglutinin and bactericidal antibody titers were not significantly different in any immunized groups.
Discussion
In this study, the virulence of GBS strains in both adult and neonate mice were high to moderate in type Ia, Ib and Ic, like as previously reports 7)11)12), and markedly low in type II like the data of Ferrieri et al.13) The virulence of strain M216 used as a test organism in this study was also like other type III strains reported3)11)12). Comparing the sensitivity of animal ages, the neonates were commonly sensitive than the adult in mice, and also in rats, using type Ia14) and type TIP). The marked difference of sensitivity to neonate of type III in this study are suggesting that the higher adhesion of type III GBS to neonatal epitherial cells than to adults as indicated by Broughton and Baker15). In administration route, type III strains showed higher virulence in IC route than in IP route at both ages. This difference is in accord with the fact that the type III is frequently caused meningitis and suggests that type III GBS might have a tropism to nurvous system.
We observed that GBS in the birth canal of normal pregnent mice was colonized for 5 days after inoculation IVg, and disappeared in following 1 to 2 weeks. When carrying the GBS at the time of parturition, pregnants and their babies have high risk of GBS infection. A part of pregnants fell in septicemia or died during the parturition. Most neonates delivered from such pregnants died of septicemia within 24hrs after birth, even survived neonates carried GBS in oral cavity and in heart blood. The active and adoptive immunization to pregnant mice significantly decreased the risk of infection to both the mother and her babies at the parturition. The litter size from immunized pregnants was significantly higher than those from not immunized.
The protective activity of the maternal serum should persist for certain period of time after passive immunization, because sera bled from the mother a week after the parturition showed still high agglutinin titer. We injected the antiserum 24 hrs before the challenge, however, the effective time interval of the antiserum injection and the challenge varied from 2.5 hrs to a few monthes by the investigators4)5)9) Both of the mixed and strain 59 antisera used for the passive immnuization showed protective potencies. Although the agglutinin titers of the serum from 59 vaccinated mice were higher than those of the other mice, bactericidal titers to 59 and M216 cells were not significantly different. These agglutinin titers would be received with effect of the group specific polysaccharide because formalinized whole bacteria were used to preparation for rabbit antisera. However the group specific polysaccharide are not protective. Therefore, the agglutinin titers in study would not be correctly parallel with protectivity against mice.
The immunization with type Ia antiserum and vaccine to pregnants effectively protected neonates they delivered against type Ia as well as type III challenge. The cross-protectivity of type III of anti-type Ia antibody is reported by Baltimore et al3)16) in mice model and by Tieffenberg et al17) in chicken model. Their reports did not clear whether the type Ia specific antigen itself has the dross-protectivity against the type III challenge. Another antigens, in addition to the type specific antigens were reported previously16). One of them is the Ibc protein antigen which is present at each types except to Ia, and they have protectivity. Other is the Iabc minor common carbohydrate antigen which is present at all I types, and they also have protectivity. Therefore, the cross-protection in this study could be due to the presence of another certain antibody produced in the mother mouse. The hypothesis would be supported by facts that the type Ia specific opsonic antibody passes the placenta18) and that the type III agglutinin does not pass19). The unknown antibody also would be passed through the placentas.
We have shown that the maternal type Ia GBS immunization either actively or adoptively was effective to protect mice from the vertical type Ia infection. Furthermore, such an immunization would give rise to
